CMS Extends National Medicare Coverage For Transcatheter Mitral Valve Repair
Executive Summary
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.
You may also be interested in...
Edwards Stays On Track For ‘Mid-Teens’ TAVR Growth In 2021
Edwards Lifesciences reported $1.2bn in sales in the first quarter of 2021, up 5% year-over-year and exceeding the projections the company offered three months ago.
Diabetes And Diagnostics Drive Abbott’s Growth In Q1
COVID-19 continues to hinder Abbott’s heart failure and neuromodulation business, but sales of COVID-19 tests drove unprecedented growth in the diagnostics business.
Edwards Keeps TAVR Going During COVID-19 Surge
Fourth-quarter sales of Edwards Sapien transcatheter aortic valve systems grew 2% year-over-year overall, despite the intense challenges created by COVID-19.